Identification of an anti-mycobacterial domain in NK-lysin and granulysin

被引:82
作者
Andreu, D
Carreño, C
Linde, C
Boman, HG
Andersson, M [1 ]
机构
[1] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden
[2] Univ Barcelona, Dept Organ Chem, E-08028 Barcelona, Spain
[3] Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden
[4] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden
关键词
antibiotic peptide; cytolytic cell; helix-loop-helix domain; synthetic peptide;
D O I
10.1042/0264-6021:3440845
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
NK-lysin and granulysin are homologous cationic anti-bacterial peptides produced by pig and human cytolytic lymphocytes, respectively. The solution structure of NK-lysin comprises five amphipathic alpha-helices. To investigate the properties of a helix-loop-helix region postulated to be a membrane-docking part of NK-lysin, we synthesized 22- and 29-residue peptides reproducing this region for both NK;lysin and granulysin. CD spectroscopy of the synthetic peptides in a liposomal solution showed spectra typical of alpha-helical peptides. The peptides were active against Gram-positive and Gram-negative bacteria, with the two NK-lysin peptides showing higher anti-bacterial activities than the two from granulysin. One NK-lysin peptide was active against Pseudomonas aeruginosa and Staphylococcus aureus, two organisms against which NK-lysin is inactive. Granulysin peptides were inactive against these bacteria, in contrast with granulysin, which is known to be active against them. Both NK-lysin and all synthetic analogues killed Mycobacterium tuberculosis and K562 tumour cells, but did not display haemolytic activity. These results identify a potent anti-mycobacterial domain in NK-lysin and granulysin consisting of a 22-residue (helix 3) sequence plus a disulphide-constrained loop.
引用
收藏
页码:845 / 849
页数:5
相关论文
共 33 条
  • [1] NK-LYSIN, A NOVEL EFFECTOR PEPTIDE OF CYTOTOXIC T-CELLS AND NK-CELLS - STRUCTURE AND CDNA CLONING OF THE PORCINE FORM, INDUCTION BY INTERLEUKIN-2, ANTIBACTERIAL AND ANTITUMOR-ACTIVITY
    ANDERSSON, M
    GUNNE, H
    AGERBERTH, B
    BOMAN, A
    BERGMAN, T
    SILLARD, R
    JORNVALL, H
    MUTT, V
    OLSSON, B
    WIGZELL, H
    DAGERLIND, A
    BOMAN, HG
    GUDMUNDSSON, GH
    [J]. EMBO JOURNAL, 1995, 14 (08) : 1615 - 1625
  • [2] Interaction of NK lysin, a peptide produced by cytolytic lymphocytes, with endotoxin
    Andersson, M
    Girard, R
    Cazenave, PA
    [J]. INFECTION AND IMMUNITY, 1999, 67 (01) : 201 - 205
  • [3] NK-lysin, a disulfide-containing effector peptide of T-lymphocytes, is reduced and inactivated by human thioredoxin reductase - Implication for a protective mechanism against NK-lysin cytotoxicity
    Andersson, M
    Holmgren, A
    Spyrou, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (17) : 10116 - 10120
  • [4] AN AMPHIPATHIC HELICAL MOTIF COMMON TO TUMOUROLYTIC POLYPEPTIDE NK-LYSIN AND PULMONARY SURFACTANT POLYPEPTIDE SP-B
    ANDERSSON, M
    CURSTEDT, T
    JORNVALL, H
    JOHANSSON, J
    [J]. FEBS LETTERS, 1995, 362 (03) : 328 - 332
  • [5] Andreu D, 1994, Methods Mol Biol, V35, P91
  • [6] Andreu D, 1998, BIOPOLYMERS, V47, P415, DOI 10.1002/(SICI)1097-0282(1998)47:6<415::AID-BIP2>3.0.CO
  • [7] 2-D
  • [8] Barany G., 1979, PEPTIDES A, V2, P1
  • [9] IDENTIFICATION OF THE BACTERICIDAL DOMAIN OF LACTOFERRIN
    BELLAMY, W
    TAKASE, M
    YAMAUCHI, K
    WAKABAYASHI, H
    KAWASE, K
    TOMITA, M
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1121 (1-2) : 130 - 136
  • [10] BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.iy.13.040195.000425